This inventor holds 1 USPTO granted patent. Top assignee: Ajinomoto Co., Ltd.. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Ken Hirose: Innovator in Therapeutic Solutions
Introduction
Ken Hirose is a notable inventor based in Kawasaki, Japan. He has made significant contributions to the field of medicine, particularly in developing therapeutic agents. His work focuses on addressing health issues that affect many individuals, showcasing his commitment to improving patient care.
Latest Patents
Ken Hirose holds a patent for a therapeutic agent aimed at treating intermittent claudication. The patent describes a compound known as 1-formyl-N-(2-(4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)) ethyl isonipecotic acid amide or an analog thereof, or a pharmaceutically acceptable salt thereof. This innovative compound provides a therapeutic solution for patients suffering from this condition, highlighting Hirose's dedication to advancing medical treatments.
Career Highlights
Throughout his career, Ken Hirose has been associated with Ajinomoto Co., Ltd., a leading company in the food and pharmaceutical industries. His role at Ajinomoto has allowed him to leverage his expertise in developing effective therapeutic agents. Hirose's work has not only contributed to the company's portfolio but has also had a positive impact on patient health.
Collaborations
Ken Hirose has collaborated with esteemed colleagues such as Hiroshi Sigematsu and Takashi Komiyama. These partnerships have fostered an environment of innovation and creativity, enabling the development of groundbreaking therapeutic solutions.
Conclusion
Ken Hirose is a distinguished inventor whose work in therapeutic agents has the potential to transform patient care. His dedication to innovation and collaboration underscores the importance of advancements in medical treatments. Through his contributions, Hirose continues to make a significant impact in the field of medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
